- Amjevita is a biosimilar copy of Abbvie’s best-selling arthritis drug Humira.
- Ahead 300 is a handheld medical device that helps clinicians diagnose a traumatic brain injury.
- Dublin-based Medtronic developed the MiniMed 670G, an artificial pancreas for patients with type 1 diabetes.
- Llaris, an anti-inflammatory drug developed by Basel, Switzerland-based Novartis, can now be used to treat three more rare auto-inflammatory diseases.
- New Brunswick, N.J.-based Johnson & Johnson’s anti-inflammatory drug Stelara can now be used to treat Crohn’s disease.
- The FreeStyle Libre Pro system is a continuous glucose monitoring system developed by Abbott Park, Ill.-based Abbott.
- Boston-based Vertex Pharmaceuticals’ cystic fibrosis drug Orkambi can now be used to treat children ages 6 to 11.
- The BD Vacutainer Barricor plasma blood collection tube separates plasma from whole blood samples.
More articles on supply chain:
Why EpiPens are so much cheaper in Europe
Uber to develop technology to connect truckers and carriers
Amgen, Arrowhead Pharma to collaborate on gene-silencing drugs
At the Becker's 11th Annual IT + Revenue Cycle Conference: The Future of AI & Digital Health, taking place September 14–17 in Chicago, healthcare executives and digital leaders from across the country will come together to explore how AI, interoperability, cybersecurity, and revenue cycle innovation are transforming care delivery, strengthening financial performance, and driving the next era of digital health. Apply for complimentary registration now.
